Estudio de factores pronósticos en carcinoma mamario en dos grupos de pacientes: Estadio 0 -21 casos- y Estadío II (con ganglios positivos) 42 casos

ANALES DEL SISTEMA SANITARIO DE NAVARRA

Suplemento 3

Estudio de factores pronósticos en carcinoma mamario en dos grupos de pacientes: Estadio 0 -21 casos- y Estadío II (con ganglios positivos) 42 casos
Study of prognostic factors in mammary carcinoma in two groups of patients: stage 0-21 cases, and Stage II (with positive ganglions) 42 cases

F. Vicente (1), B. Larrinaga (2), P. Soriano (1), M.L. Gómez (2), J.M. Lera (1).

(1) Servicio de Cirugía General.
(2) Servicio de Anatomía Patológica. Hospital de Navarra.

BIBLIOGRAFÍA

1. Parkin DM, Pisani P, Ferlay J. Estimates of world-vide frecuency of sixteen major cancers. 1985. Int J Cancer 1993; 54: 594-606.

2. Kelsey JL, Hildreth NG, Thompson WD. Epidemiologic aspects of breast cancer. Radiol Clin North Am 1983; 21: 3-12.

3. Ascunce N, del Moral A. Programa de detección precoz del cáncer de mama en Navarra. Gobierno de Navarra. Departamento de Salud. 1991.

4. Johnstone FR. Carcinoma of the breast: Influence of size of primary lesion and life node involment based on selective biopsy. Am J Surg 1972; 124: 158-164.

5. International Breast Cancer Study Group. Prognostic importance of occult axilary limph node micrometastases from breast cancer. Lancet 1990; 335: 1565-1568.

6. Almendral JM, Huebsch D, Blundell PA, Macdonall-Bravo H, Bravo R. Cloning and sequence of human nuclear protein cyclin: homology with ADN binding proteins. Proc Natl Acad Sci USA 1987; 84: 1575-1579.

7. Meyer JS. Ceell kinetics of breast and breast tumors. En: Cancer of the breast. Donegan and Spratt 4th edition. W. B. Saunders Company. 1995.

8. Syvaoja JE. DNA polymerasa epsilon: The latest member in the family of mammalian DNA polymerases Bioessays 1990; 12: 533-536.

9. Goulian M, Herrmann SM, Sackett JW, Grimm SL. Two forms of DNA polymerase delta from mouse cells. Purification and properties. J Biol Chem 1990; 265: 16402-16411.

10. Bravo R, Frank R, Blundell PA, Mc Donald-Bravo H. Cyclin/PCNA is the auxiliary protein of ADN polymerasa delta. Nature 1987; 326: 515-517.

11. Celis JE, Celis A. Cell cycle dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cell: Subdivision of S phase. Proc Natl Acad Sci USA 1985; 82: 3262-3266.

12. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.

13. Kaplan E.L, Meier P. Nonparametric stimations from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.

14. Mantel N, Haenzel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.

15. Miyachi K, Fritzler MJ, Tan EM. Auto antibodies to a nuclear antigen in proliferating cells. J Immunol 1978; 121: 2228-2234.

16. Hsu SM, Raine L, Ranger H. Use of avidinbiotin peroxidase complex ABC in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody PAP procedure. J Histochem Cytochem 1981; 29: 557-580.

17. Haerslev T, Jacobsen GK. Proliferating cell nuclear antigen in breast carcinomas. An immunohistochemical study with correlation to histopathological features and prognostic factors. Virchows Arch 1994; 424: 39-46.

18. Robbins BA, De la Vega D, Ogata K, Tan EM, Nakamura RM. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pahol Lab Med 1987; 111: 841-845.

19. Schönborn Y, Minguillon C, Möhner M, Ebeling K. PCNA as a potential prognostic marker in breast cancer. Breast 1994; 3: 97-102.

20. Siitonen SM, Isola JJ, Rantal IS, Helin HJ. Intratumor variation in cell proliferation in breast carcinoma as determined by anti-PCNA monoclonal antibody and automated image analysis. Am J Clin Pathol 1993; 99: 226-231.

21. Tahan SR, Neuberg DS, Dieffenbach A, Yacoub L. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer 1993; 71: 3552-3559.

22. Gasparini S, Meli S, Pozza S, Cazzavillan S, Bealiacqua P. PC-10 antibody to proliferating cell nuclear antigen PCNA is not related to prognosis in human breast carcinomas. Growth Reg 1992; 2: 145-150.